|Articles|October 21, 2020
From data integrity regulations to Pharma 4.0
Author(s)Thermo Fisher Scientific
This white paper will give readers a vendor’s perspective on recent trends in regulations and the potential future direction for the industry - being referred to as “Pharma 4.0”.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
